Published in Am J Gastroenterol on March 01, 2010
Nine scoring models for short-term mortality in alcoholic hepatitis: cross-validation in a biopsy-proven cohort. Aliment Pharmacol Ther (2014) 3.98
Diagnosis and Treatment of Alcoholic Hepatitis: A Systematic Review. Alcohol Clin Exp Res (2016) 0.77
Practical Concerns and Controversies in the Management of Alcoholic Hepatitis. Gastroenterol Hepatol (N Y) (2016) 0.75
A new scoring system for prognostic stratification of patients with alcoholic hepatitis. Am J Gastroenterol (2008) 2.35
Steatohepatitis: a tale of two "hits"? Gastroenterology (1998) 13.21
Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications. Lancet (1999) 7.39
Peginterferon alfa-2a in patients with chronic hepatitis C. N Engl J Med (2000) 5.58
Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus. J Infect Dis (1997) 3.88
The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology (1995) 3.73
Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance. J Hepatol (1998) 3.57
Prednisolone or pentoxifylline for alcoholic hepatitis. N Engl J Med (2015) 3.47
Should methionine be added to every paracetamol tablet? BMJ (1997) 3.33
Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed. Hepatology (2009) 3.20
Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial. Lancet (2000) 2.72
Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver. Lancet (1995) 2.64
Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score. Gut (2005) 2.62
Clinical significance of intrahepatic hepatitis C virus levels in patients with chronic HCV infection. Gut (1998) 2.45
Detection of biofilm formation among the clinical isolates of Staphylococci: an evaluation of three different screening methods. Indian J Med Microbiol (2006) 2.43
Hepatotoxicity of herbal remedies. BMJ (1989) 2.37
UK guidelines on the management of variceal haemorrhage in cirrhotic patients. British Society of Gastroenterology. Gut (2000) 2.33
Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data. Int J Cancer (1997) 2.30
Selection of patients for liver transplantation and allocation of donated livers in the UK. Gut (2007) 2.20
Professional athletes suffering from familial hypercholesterolaemia rarely tolerate statin treatment because of muscular problems. Br J Clin Pharmacol (2004) 2.18
Primary prophylaxis of variceal hemorrhage: a randomized controlled trial comparing band ligation, propranolol, and isosorbide mononitrate. Gastroenterology (2002) 2.17
Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study. Lancet (2000) 1.99
Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis. Hepatology (1997) 1.94
Total therapy with tandem transplants for newly diagnosed multiple myeloma. Blood (1999) 1.89
Moderate hypothermia for uncontrolled intracranial hypertension in acute liver failure. Lancet (1999) 1.89
Review article: omega-3 fatty acids - a promising novel therapy for non-alcoholic fatty liver disease. Aliment Pharmacol Ther (2010) 1.87
Exercise-induced left ventricular dysfunction in alcoholic and non-alcoholic cirrhosis. J Hepatol (1995) 1.84
Clinical diagnostic scale: a useful tool in the evaluation of suspected hepatotoxic adverse drug reactions. J Hepatol (2000) 1.84
Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C. Hepatology (1998) 1.84
Mutations in CTC1, encoding conserved telomere maintenance component 1, cause Coats plus. Nat Genet (2012) 1.82
Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders. Mol Psychiatry (2002) 1.81
p53 expression in colorectal tumors. Am J Pathol (1991) 1.77
Sclerosing encapsulating peritonitis after orthotopic liver transplantation. Am J Surg (2001) 1.74
Clinical guidelines on the management of hepatitis C. Gut (2001) 1.72
Stent-assisted coiling versus balloon remodeling of wide-neck aneurysms: comparison of angiographic outcomes. AJNR Am J Neuroradiol (2013) 1.69
Evidence for an immune response to HLA class I antigens in the vanishing-bileduct syndrome after liver transplantation. Lancet (1987) 1.68
Interleukin 10 promoter region polymorphisms and susceptibility to advanced alcoholic liver disease. Gut (2000) 1.68
A double blind placebo controlled crossover study of prostacyclin in man. Life Sci (1979) 1.67
Morphometry of the human pulmonary arterial tree. Circ Res (1973) 1.65
The outcome of the first 165 orthotopic liver transplants in Scotland. Scott Med J (1999) 1.63
Motivational aspects of deliberate self-poisoning in adolescents. Br J Psychiatry (1982) 1.62
Adolescents who take overdoses: their characteristics, problems and contacts with helping agencies. Br J Psychiatry (1982) 1.59
Hepatic encephalopathy and ascites. Lancet (1997) 1.57
Antibiotic prophylaxis for percutaneous endoscopic gastrostomy for non-malignant conditions: a double-blind prospective randomized controlled trial. Aliment Pharmacol Ther (2005) 1.55
Randomised clinical study: comparison of acceptability, patient tolerance, cardiac stress and endoscopic views in transnasal and transoral endoscopy under local anaesthetic. Aliment Pharmacol Ther (2014) 1.54
A comparative study of emergency transjugular intrahepatic portosystemic stent-shunt and esophageal transection in the management of uncontrolled variceal hemorrhage. Am J Gastroenterol (1995) 1.52
Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole. Bone Marrow Transplant (2007) 1.51
Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients. Antimicrob Agents Chemother (2000) 1.50
Natural history of NAFLD: remarkably benign in the absence of cirrhosis. Gastroenterology (2005) 1.50
Does donor-recipient ABO incompatibility protect against relapse after allogeneic bone marrow transplantation in first remission acute myeloid leukemia? Bone Marrow Transplant (2002) 1.49
Review article: the management of acute variceal bleeding. Aliment Pharmacol Ther (2003) 1.49
TIPSS 10 years on. Gut (2000) 1.48
Elevation of intracranial pressure following transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage. J Hepatol (1997) 1.48
Side effects occurring during administration of epoprostenol (prostacyclin, PGI2), in man. Br J Clin Pharmacol (1982) 1.48
A randomized trial of solvent/detergent-treated and standard fresh-frozen plasma in the coagulopathy of liver disease and liver transplantation. Transfusion (2000) 1.48
The effect of polymorphisms in tumor necrosis factor-alpha, interleukin-10, and transforming growth factor-beta1 genes in acute hepatic allograft rejection. Transplantation (2000) 1.47
Bedside leucocyte esterase reagent strips with spectrophotometric analysis to rapidly exclude spontaneous bacterial peritonitis: a pilot study. Eur J Gastroenterol Hepatol (2007) 1.47
Peripheral blood stem cell transplantation may result in increased relapse of acute myeloid leukaemia due to reinfusion of a higher number of malignant cells. Bone Marrow Transplant (1995) 1.45
Fatal systemic lupus erythematosus in patient taking oral iron chelator L1. Lancet (1991) 1.44
Platelet lipoxygenase defect (Wien-Penzing defect) in two patients with myocardial infarction. Am J Hematol (1991) 1.43
Osteonecrosis of the jaw complicating bisphosphonate treatment for bone disease in multiple myeloma: an overview with recommendations for prevention and treatment. Intern Med J (2008) 1.43
The natural history of histologically proved drug induced liver disease. Gut (1999) 1.43
Hepatotoxicity of sodium stibogluconate in leishmaniasis. Lancet (1993) 1.42
Cervical tuberculous lymphadenopathy: changing clinical pattern and concepts in management. Postgrad Med J (2001) 1.42
Low level or absent in vivo replication of hepatitis C virus and hepatitis G virus/GB virus C in peripheral blood mononuclear cells. J Gen Virol (1998) 1.42
How long after neutrophil recovery should myeloid growth factors be continued in autologous hematopoietic stem cell transplant recipients? Bone Marrow Transplant (2004) 1.41
Risk of intentional reversible thrombosis of transjugular intrahepatic portosystemic shunt. Radiology (1995) 1.40
Successful pregnancy in a patient with type III glycogen storage disease managed with cornstarch supplements. Br J Obstet Gynaecol (1998) 1.40
The sequential organ failure assessment (SOFA) score is an effective triage marker following staggered paracetamol (acetaminophen) overdose. Aliment Pharmacol Ther (2012) 1.40
Aplastic crisis and leg ulceration: two rare complications of hereditary sideroblastic anaemia. J Assoc Physicians India (1992) 1.39
A randomized trial comparing transjugular intrahepatic portosystemic stent-shunt with variceal band ligation in the prevention of rebleeding from esophageal varices. Hepatology (1997) 1.39
The hands in alcoholic liver disease. Am J Gastroenterol (1991) 1.39
Diagnosis and interpretation of steatosis and steatohepatitis. Semin Diagn Pathol (1998) 1.39
Normal venous circulation of the gastroesophageal junction. A route to understanding varices. Gastroenterology (1987) 1.39
Direct measurement of pulsatile insulin secretion from the portal vein in human subjects. J Clin Endocrinol Metab (2000) 1.38
A Clinical Trial of Nitrosense patch for the treatment of patients with painful diabetic neuropathy. J Assoc Physicians India (2014) 1.38
Bleeding ectopic varices in cirrhosis: the role of transjugular intrahepatic portosystemic stent shunts. Aliment Pharmacol Ther (2008) 1.38
Noninvasive assessment of the cardiovascular effects of prostacyclin (PGI2) in man. Eur J Cardiol (1980) 1.36
Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy: implications for amyloid fibrillogenesis. Transplantation (1998) 1.35
Stenoses of vascular anastomoses after hepatic transplantation: treatment with balloon angioplasty. AJR Am J Roentgenol (1991) 1.34
Inter-laboratory comparison of the CD-1 neonatal mouse logistic dose-response model for Cryptosporidium parvum oocysts. J Eukaryot Microbiol (2000) 1.32
Accuracy of hepatic adverse drug reaction reporting in one English health region. BMJ (1999) 1.31
Effects of intravenous infusion of prostacyclin (PGI2) in man. Prostaglandins (1980) 1.30
Distinct patterns of chemokine expression are associated with leukocyte recruitment in alcoholic hepatitis and alcoholic cirrhosis. J Pathol (1998) 1.29
Alcoholic liver disease: new insights into mechanisms and preventative strategies. Trends Mol Med (2001) 1.26
Candidate gene case-control association studies: advantages and potential pitfalls. Br J Clin Pharmacol (2001) 1.24
Age is not a prognostic variable with autotransplants for multiple myeloma. Blood (1999) 1.23
Tumour necrosis factor-alpha promoter polymorphisms in primary biliary cirrhosis. J Hepatol (1999) 1.20
Sodium handling in patients with well compensated cirrhosis is dependent on the severity of liver disease and portal pressure. Gut (2000) 1.20
Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis. Gut (2005) 1.19